NTT Named a Leader in the 2022 Gartner® Magic Quadrant™ for Network Services, Global
Positioned Highest for “Completeness of Vision” and “Ability to Execute” in 2022 NTT recognized as…
4 years ago
Wire Stories
Erdenes Tavantolgoi JSC (ETT) Holds its Annual General Meeting and Vows to Create 21,000 Jobs By 2025.
ULAANBAATAR, Mongolia--(BUSINESS WIRE)--The Annual General Meeting of Erdenes Tavantolgoi JSC, one of the largest mining…
4 years ago
Renesas Announces Acquisition of and Tender Offer for Own Shares
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (“Renesas”, TSE:6723), a premier supplier of advanced semiconductor solutions, today announced…
4 years ago
Renesas Reports Financial Results for the First Quarter Ended March 31, 2022
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for…
4 years ago
iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement
PixoTech® licensing shifted in as iXensor's new growth engine to meet self-testing strong demand in…
4 years ago
Kioxia to Donate 100 Million Yen in Humanitarian Assistance for the People of Ukraine
TOKYO--(BUSINESS WIRE)--Kioxia Corporation today announced it is making a donation of 100 million yen to…
4 years ago
Vishal Gupta Joins TA Associates as Director in Mumbai
BOSTON & MUMBAI, India--(BUSINESS WIRE)--TA Associates, a leading global growth private equity firm, today announced…
4 years ago
2ND STREET TAIWAN CO., LTD. to Open a Ninth Store in Taiwan, 2nd STREET Taoyuan Tonlin, on May 13, 2022, in Taoyuan City, Taiwan
NAGOYA, Japan--(BUSINESS WIRE)--#Secondhandclothing--2ND STREET TAIWAN CO., LTD., a subsidiary of GEO Holdings (TOKYO:2681), is set…
4 years ago
Asahi Group Holdings Adopts Box as a Hub for Centralized Management of Company-Wide Content
Box to be the key foundation for a new flexible and fast-paced IT architecture TOKYO--(BUSINESS…
4 years ago
ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Low Metastatic Breast Cancer
Based on DESTINY-Breast04 results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated significant improvement in both…
4 years ago